T1	Participants 210 254	patients with manic and mixed mood episodes,
T2	Participants 486 532	patients presenting with a mixed index episode
T3	Participants 603 725	Patients who met remission criteria at 2 consecutive weekly visits during 6 to 12 weeks of open-label olanzapine treatment
T4	Participants 975 987	304 patients